The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Z. W.
Right arrow Articles by Letvin, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Z. W.
Right arrow Articles by Letvin, N. L.
The Journal of Immunology, 2001, 166: 4525-4533.
Copyright © 2001 by The American Association of Immunologists

The TCR Repertoire of an Immunodominant CD8+ T Lymphocyte Population1

Zheng W. Chen2, Yunyuan Li, Xuejun Zeng, Marcelo J. Kuroda, Jöern E. Schmitz, Yun Shen, Xioamin Lai, Ling Shen and Norman L. Letvin

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The TCR repertoire of an epitope-specific CD8+ T cell population remains poorly characterized. To determine the breadth of the TCR repertoire of a CD8+ T cell population that recognizes a dominant epitope of the AIDS virus, the CD8+ T cells recognizing the tetrameric Mamu-A*01/p11C,CM complex were isolated from simian immunodeficiency virus (SIV)-infected Mamu-A*01+ rhesus monkeys. This CD8+ T cell population exhibited selected usage of TCR V{beta} families and complementarity-determining region 3 (CDR3) segments. Although the epitope-specific CD8+ T cell response was clearly polyclonal, a dominance of selected V{beta}+ cell subpopulations and clones was seen in the TCR repertoire. Interestingly, some of the selected V{beta}+ cell subpopulations and clones maintained their dominance in the TCR repertoire over time after infection with SIV of macaques. Other V{beta}+ cell subpopulations declined over time in their relative representation and were replaced by newly evolving clones that became dominant. The present study provides molecular evidence indicating that the TCR repertoire shaped by a single viral epitope is dominated at any point in time by selected V{beta}+ cell subpopulations and clones and suggests that dominant V{beta}+ cell subpopulations and clones can either be stable or evolve during a chronic infection.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The CD8+ CTL play an important role in the immune containment of HIV-1 and SIV replication. The emergence of virus-specific CTL during primary HIV-1 and SIV infection is associated with a reduction in early viremia (1, 2, 3, 4). Moreover, high-frequency virus-specific CTL responses appear to contribute to a decrease in virus load and a delay in disease progression in chronically HIV-1-infected persons (5, 6, 7, 8). In fact, monoclonal anti-CD8 Ab-mediated depletion of CD8+ T lymphocytes in SIV-infected monkeys was associated with a marked increase in viral load (4, 9). In view of the importance of virus-specific CTL in AIDS immunopathogenesis, it is imperative that we understand this immune response at a cellular and molecular level.

Although virus-specific CTL have been extensively studied in the setting of HIV-1 infections, the TCR repertoire of CD8+ T cell responses specific for individual viral epitopes remains poorly characterized in infected individuals. To date, TCR repertoires of epitope-specific CTL have been studied by analyzing either the entire CD8+ T cell population or a limited number of CTL clones isolated from PBL of infected individuals (2, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19). Therefore, those studies have provided limited information concerning the molecular evolution of epitope-specific CD8+ T cells. Further studies of CD8+ T cell populations that recognize specific peptide/MHC class I complexes are needed to characterize the TCR repertoire of these epitope-specific CD8+ T lymphocytes.

The recent development of soluble tetrameric MHC class I/peptide complexes has allowed us to visualize and isolate epitope-specific CD8+ T cell populations from HIV-1-infected humans and SIV-infected monkeys (20, 21). This technology has facilitated an in-depth analysis of rhesus monkey CD8+ CTL specific for the dominant SIV Gag epitope p11C,C-M presented to T lymphocytes by the MHC class I allele Mamu-A*01. In a previous study, we have assessed TCR gene expression in a series of CTL clones that recognize this SIV Gag epitope (10). In the present study, we have used the tetrameric Mamu-A*01/p11C,C-M complex to characterize the TCR repertoire of this epitope-specific CD8+ T cell population and define the clonality of this immune response.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals and viruses

Rhesus monkeys (Macaca mulatta) were used in these studies. These animals were maintained in accordance with the guidelines of the Committee on Animals for Harvard Medical School and the "Guide for the Care and Use of Laboratory Animals" (National Academy Press, 1996). The rhesus monkeys were inoculated i.v. with SIV of macaques (SIVmac)3251 as described (21). All rhesus monkeys used in this study were Mamu-A*01+ as determined both by PCR-based MHC class I typing and by functional CTL assays as described previously (21).

Staining and sorting of CD8+ T cell subsets

Soluble tetrameric Mamu-A*01/p11C,C-M complex was made as previously described (21). The tetramer was produced by mixing biotinylated Mamu-A*01/p11C,C-M complex with PE-labeled streptavidin (Prozyme, San Leandro, CA) at a molar ratio of 4:1. The PE-coupled tetrameric Mamu-A*01/p11C,C-M complex was used in conjunction with anti-CD8{alpha} (Leu2a)-FITC (Becton Dickinson, San Jose, CA), anti-CD8{alpha}{beta} (2ST8–5H7)-ECD (Beckman Coulter, Miami, FL) and anti-rhesus monkey CD3(FN18) directly coupled to APC. PE-coupled tetrameric Mamu-A*01/p11C,C-M complex was used in conjunction with the directly labeled mAbs to stain either PBMC or single cells from lymph nodes or spleen isolated by density-gradient centrifugation over Ficoll-Hypaque. Sorting of potentially biohazardous specimens was performed on a Coulter EPICS Elite ESP (Beckman Coulter) located in a dedicated BSL-3 area. The sorter was set electronically to achieve enrichments of selected cell subsets of >99%. As a control study, the frequency of the tetramer-staining CD8+ T cells in uninfected animals also was determined. In our accumulating studies, CD8+ T cells recognizing tetrameric Mamu-A*01/p11C,CM were either undetectable or constituted <0.1% of CD8+ T cells in naive Mamu-A*01+ macaques.

RNA extraction and cDNA synthesis

RNA was extracted from p11C,C-M/Mamu*01 tetramer binding or nonbinding CD8+ T cell populations according to the instructions of the RNA extraction kit from Qiagen (Valencia, CA). cDNA was synthesized by using a method based on the switching mechanism at the 5' end of the RNA template (22, 23). The protocol was modified from the instructions in the SMART cDNA Synthesis Kit from Clontech Laboratories (Palo Alto, CA). Briefly, the cDNA reaction was catalyzed by using Moloney murine leukemia virus reverse transcriptase (Life Technologies, Rockville, MD), the SMART primer provided in the Clontech Kit and a modified cDNA synthesis primer. The sequence for the modified cDNA synthesis primer was 5'-AAGCAGTGGTAACAACGCAGAGTACT(30)NV-3' (N = A, C,G, or T; V = A, G, or C.). The double-stranded cDNA was made by a 10-cycle PCR with the primer and reagents provided in the SMART cDNA synthesis kit from Clontech Laboratories. In control experiments to validate the use of SMART cDNA synthesis in the present studies, SMART cDNA, cDNA that was synthesized by conventional methods, and cDNA derived from anchored PCR were all assessed for V{beta} gene expression (17, 24). Similar expression patterns of V{beta} gene families were seen in these different cDNA samples (data not shown).

TCR V{beta} family expression

PCR-based quantitation of V{beta} family expression was undertaken as described previously (25). Briefly, cDNA derived from each sample was aliquoted into 25 tubes, each containing a sense V{beta} family-specific and an antisense C{beta}-specific primer. As an internal control, each reaction tube also contained a pair of primers that amplified a 105-bp fragment of the constant region of macaque TCR {alpha}-chain. The PCR was performed for 28 cycles, with each cycle at 95°C for 30 s, 60°C for 1 min, and 72°C for 2 min. The radiolabeled PCR products were electrophoresed through a 5% polyacrylamide gel, dried, and exposed to x-ray film. The separated V{beta}-C{beta} and C{alpha}-C{alpha} bands were measured for the radioactivity with an Ambis 100 (Ambis, San Diego, CA) or for density by a GS-700 Densitometer (Bio-Lab, Richmond, CA). To confirm the results of V{beta} family expression, the identified V{beta} families in each cDNA sample were assessed for complementarity-determining region 3 (CDR3) profiles through Genescan-based spectrotyping.

TCR {beta} CDR3 profile analysis

CDR3 profiles were analyzed by Genescan-based spectrotyping (26). cDNAs were amplified by PCR for expression of 24 V{beta} families by using individual V{beta}-specific primers and a C{beta}-specific primer as described previously (25, 26, 27). The second round of PCR was performed with nested V{beta} primers and a C{beta} primer, designed as described (26). The internal C{beta} primer was labeled at its 5' end with the Fam fluorophore (Applied Biosystems, Foster City, CA). The first-round PCR products were amplified for 15 cycles under the following conditions: 95°C for 30 s, 55°C for 30 s, and 72°C for 30 s. One microliter of each reaction product was mixed with deionized formamide and a ROCK-500 size standard and then electrophoresed on a 5% acrylamide gel on a 377 DNA sequencer (Applied Biosystems). Data were analyzed for size and fluorescence intensity by using the Genescan software (Applied Biosystems). Experiments performed on samples obtained at three different times from four normal monkeys indicated that these CDR3 length analyses were highly reproducible and V{beta}-specific. Further cloning and sequencing in conjunction with the CDR3 length display allowed the prediction of CDR3 lengths. These lengths were expressed as predicted numbers of amino acids.

Sequencing and frequency analyses of TCR {beta} cDNA clones isolated from the tetramer-binding CD8+ T cells

The nonselective cloning and sequencing of TCR {beta} cDNA were done by using a technique modified from the anchored PCR, as described previously (24). The TCR {beta} cDNA was isolated from the SMART cDNA with the SMART primer (Clontech Laboratories) containing an EcoRI site and a C{beta} primer containing an XbaI site. The PCR was performed for 30 cycles under the following conditions: 95°C for 30 s, 60°C for 1 min, and 72°C for 2 min. The PCR products were digested with EcoRI and XbaI and ligated into the pSP65 plasmid (Promega, Madison, WI) for cloning and sequencing (2). For frequency analyses, 80–120 clones were sequenced and analyzed for each cDNA sample. The frequency of the individual clones was determined based on the percentage of each clone in the total clones isolated from each cDNA sample.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Limited diversity of the TCR V{beta} repertoire in CD8+ T cell populations that recognize the tetrameric Mamu-A*01/p11C,CM complex

To directly examine the TCR repertoire of a single viral epitope-specific CD8+ T cell population during an AIDS virus infection, tetrameric Mamu-A*01/p11C,C-M complex-binding CD8+ T cell populations from SIVmac-infected, Mamu-A*01+ rhesus monkeys were isolated and assessed for their expression of 24 V{beta} gene families. The CD8+ T cell populations recognizing this tetrameric Mamu-A*01/p11C,C-M complex were detectable in PBL of acutely and chronically SIVmac-infected monkeys (Fig. 1Go). The tetrameric Mamu-A*01/p11C,CM complex-bound CD8+ T cells were isolated by flow cytometric sorting and assessed for their TCR V{beta} repertoire. A limited diversity of TCR V{beta} gene usage was seen in the tetrameric Mamu-A*01/p11C,C-M complex-bound CD8+ T cell populations. The tetrameric Mamu-A*01/p11C,CM complex-bound CD8+ T cell populations predominantely expressed TCR with certain V{beta} gene family members (Fig. 2Go). Interestingly, a V{beta}13-expressing cell subpopulation was consistently dominant in the tetrameric Mamu-A*01/p11C,C-M complex-bound CD8+ T cell populations from the monkeys examined. The V{beta}13-expressing cell populations constituted from 17 to 48% of the tetramer+ CD8+ T cell populations sorted from the PBL of the SIVmac-infected monkeys (Fig. 2Go). In contrast, the CD8+ T cell populations derived from the PBL of the same monkeys that did not bind to tetrameric Mamu-A*01/p11C,CM complex exhibited a diverse TCR V{beta} repertoire. All 24 V{beta} families were expressed in these tetramer-negative cell populations (Fig. 2Go). Therefore, these results suggested that the tetrameric Mamu-A*01/p11C,C-M complex interacted with only selected CD8+ T cell subpopulations.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 1. Detectable CD8+ T cell populations that recognize the tetrameric Mamu-A*01/p11C,C-M complex in SIVmac-infected, Mamu-A*01+ rhesus monkeys. Data were derived from the flow cytometric analysis and showed the percentage of tetramer+ cells in CD8+ T cells at the time the cells were sorted for molecular analysis.

 


View larger version (29K):
[in this window]
[in a new window]
 
FIGURE 2. Limited diversity of the TCR V{beta} repertoire of the CD8+ T cell population that recognizes the Mamu-A*01/p11C,C-M complex. The data shown on the left were derived from the CD8+ T cells that bound to the tetrameric Mamu-A*01/p11C,C-M complex (tetramer+), whereas those on the right were derived from the cells that did not bind the tetramer (tetramer-). These CD8+ T cell populations were isolated by sorting PBL obtained 2 wk (from two monkeys, Mm8898 and Mm8798) and 2–5 years (from three other animals) after SIVmac infection. The representation of individual V{beta} families in a lymphocyte population are shown as a percentage of the expression of all of the 24 families (25 ).

 
Restricted CDR3 profiles in the V{beta}+CD8+ T cell populations that recognize tetrameric Mamu-A*01/p11C,CM complex

To determine whether the CD8+ T cells that recognize this single SIV Gag epitope are restricted in the CDR3 regions they use, we examined the CDR3 profiles of selected V{beta}-expressing cell subpopulations in the tetrameric Mamu-A*01/p11C,C-M complex-bound CD8+ T cell population. CDR3 spectrotyping analysis revealed a restricted pattern of CDR3 profiles in the selected V{beta}-expressing CD8+ T cell subpopulations that recognize the tetrameric Mamu-A*01/p11C,C-M complex. A CDR3 of a single length was identified in the majority of these selected V{beta}-expressing CD8+ T cell subpopulations, whereas the CD8+ T cells that did not bind the tetramer displayed multiple CDR3 lengths (Fig. 3Go). A CDR3 length of 11 aa appeared to be the most frequently used by the selected V{beta}+CD8+ T cell subpopulations in the tetramer-bound lymphocytes (Fig. 3Go). These results extend the studies of V{beta} family expression described above and demonstrate at a CDR3 level the limited diversity of TCR repertoire in the CD8+ T cell subpopulations that bind to the tetrameric Mamu-A*01/p11C,C-M complex.



View larger version (42K):
[in this window]
[in a new window]
 
FIGURE 3. Restricted CDR3 profiles in the selected V{beta}+CD8+ T cell subpopulations that recognize the tetrameric Mamu-A*01/p11C,C-M complex. Shown are histograms generated in the spectrotyping analysis of CDR3 lengths used by selected V{beta}+ subpopulations of the tetramer-positive (tetramer+) and -negative (tetramer-) CD8+ T cell populations. Monkey designations are noted at the top of this figure. Fragment lengths in nucleotide numbers are displayed on the x-axis and fluorescence intensity on the y-axis. The number of nucleotides in the different CDR3 lengths were determined in control experiments (see Materials and Methods) and are expressed as predicted number of amino acids. The short line at the bottom of each histogram represents the CDR3 length of 10 aa. Shown are only those histograms of V{beta} families in which CDR3 profiles were identified in the cDNA from the purified tetramer+ CD8+ cells and the corresponding V{beta} families from the control tetramer- CD8+ cells. The infection status of the animals and the time following infection at which tetramer+ and tetramer- CD8+ T cells were obtained are the same as described in the legend of Fig. 2Go.

 
Clonal dominance in the V{beta}+CD8+ T cell populations that recognize tetrameric Mamu-A*01/p11C,CM complex

As a complementary study, sequencing of TCR {beta} cDNA was used to characterize the TCR repertoire and clonality of the CD8+ T cell population that binds to the tetrameric Mamu-A*01/p11C,C-M complex. These sequence analyses yielded results similar to those shown in the PCR-based quantitation of V{beta} gene family expression and the CDR3 profile studies. A predominant use of the sellected V{beta} gene families was seen at the sequence level in the CD8+ T cell population that bound to the tetrameric Mamu-A*01/p11C,C-M complex (Figs. 2Go and 4Go, A and B). These selected V{beta}+CD8+ T cell subpopulations exhibited monoclonal or oligoclonal dominance and restricted CDR3 lengths. Nevertheless, the CD8+ T cell populations recognizing the tetrameric Mamu-A*01/p11C,C-M complex were clearly polyclonal (Fig. 4Go). Furthermore, the number of dominant clones in the CD8+ T cell populations that bound the tetrameric Mamu-A*01/p11C,C-M complex appeared to be smaller during the chronic than during the acute phase of SIVmac infection (Fig. 4Go, A and B). These results provide further evidence that SIVmac-infected Mamu A*01+ rhesus monkeys develop a p11C-specific CD8+ T cell response comprised of limited numbers of V{beta}-expressing cell subpopulations.




View larger version (83K):
[in this window]
[in a new window]
 
FIGURE 4. Clonal dominance in the V{beta} repertoires of the CD8+ T cell populations recognizing the Mamu-A*01/p11C,C-M tetramer complex. A nonselective cloning strategy for TCR {beta} sequences was used (see Materials and Methods) with the cDNA prepared from the tetramer+ CD8+ T cells isolated through cell sorting. The frequency of clonatypic sequences is expressed as the percentage of that clone among the total clones identified in the cDNA from the tetramer+ CD8+ T cells.

 
Dominant V{beta}+ cell subpopulations or clones in the p11C-specific CD8+ T cell population can change during the course of SIVmac infections

Finally, we sought to examine the temporal evolution of the TCR repertoire of the CD8+ T cell populations that recognize the tetrameric Mamu-A*01/p11C,C-M complex. Cells that bound to the tetrameric Mamu-A*01/p11C,C-M complex were isolated by sorting PBL of two Mamu-A*01+ rhesus monkeys 0.5, 2, and 7 mo after SIVmac infection (Fig. 5Go). Although some selected V{beta}+CD8+ T cell subpopulations maintained their clonal dominance over time, others fluctuated in their clonal representation in the TCR repertoire. These varied patterns of clonal evolution were seen at both the level of V{beta} family expression and CDR3 profiles during the 7-mo follow-up of the SIVmac-infected monkeys (Figs. 6Go and 7Go). Some of the clones identified in PBL during the period of acute infection maintained their dominance in the repertoire of the tetramer-binding CD8+ T cell populations, whereas others were either lost or decreased in the frequency of their representation within this cell population (Fig. 8Go). Interestingly, those clones that lost their dominance over time appeared to be replaced by newly evolving clones that became dominant during chronic SIVmac infection (Fig. 8Go). Therefore, these results provide molecular evidence that dominant V{beta}+ cell subpopulations or clones in the repertoire of the p11C-specific CD8+ T cell population can be stable or changing during the course of SIVmac infections.



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 5. CD8+ T cell populations that recognize the tetrameric Mamu-A*01/p11C,C-M complex were detectable over time after SIVmac infection in the monkeys. The legend is the same as that to Fig. 1Go.

 


View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 6. Evolution of tetramer-binding CD8+ T cell subpopulations. Shown was the analysis of the V{beta} family expression in the tetramer-binding CD8+ T cell populations obtained from PBL of two monkeys 0.5, 2, and 7 mo after infection.

 


View larger version (48K):
[in this window]
[in a new window]
 
FIGURE 7. Evolution of the CDR3 profiles of tetramer-binding CD8+ T cell population. Shown is the analysis of the CDR3 profiles of selected V{beta}-expressing cell subpopulations in the tetramer-binding CD8+ T cell population obtained from PBL of two monkeys 0.5, 2, and 7 mo after infection.

 


View larger version (47K):
[in this window]
[in a new window]
 
FIGURE 8. Evolution of dominant clones in tetramer-binding CD8+ T cell population. Shown is the frequency analyses of particular TCR {beta} clones. These analyses show that the dominant clones in the tetramer-binding CD8+ T cell population can be either stable or replaced during the course of SIVmac infections. Sequencing and frequency analyses were performed as described in the legend to Fig. 4Go.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The present study represents the first extensive characterization in AIDS virus-infected individuals of the TCR repertoire of a CD8+ T cell population that recognizes a tetrameric MHC class I/peptide complex. This study extends our previously reported experiments in which p11C-specific CTL clones were generated from PBL of chronically SIVmac-infected Mamu-A*01+ rhesus monkeys and assessed for TCR gene usage (10). An in vitro bias may have been introduced in that earlier study, because TCR V gene usage was determined for cellular clones generated from PBL populations that were cultured following Ag stimulation. The evaluation of tetramer binding cells in the present study allowed us to evaluate TCR V{beta} gene usage in cells that had not been manipulated in vitro. Moreover, this approach allowed us to characterize TCR V{beta} gene usage in larger numbers of cells than had been studied in the earlier experiments. The earlier experiments showed that p11C-specific CTL clones can be restricted predominately to T cell subpopulations expressing members of the V{beta}6 or V{beta}13 family of genes (10). In fact, the V{beta} families used by those CTL clones were dominant within the TCR V{beta} repertoire identified in the present study in the CD8+ T cell population recognizing the Mamu-A*01/p11C,CM complex. However, T cell subpopulations expressing V{beta} families other than V{beta}6 and V{beta}13 also were identified in the CD8+ T cell population recognizing the Mamu-A*01/p11C,C-M complex. Therefore, the results of the present study complement these earlier studies, demonstrating the broad TCR repertoire shaped by the Mamu-A*01/p11C,CM complex during SIVmac infection.

The patterns of V{beta} dominance in the Mamu-A*01/p11C,C-M tetramer-binding CD8+ T cell populations varied among individual SIVmac-infected monkeys. The differences among the monkeys is unlikely to be a result of biases introduced by the molecular analyses themselves, because differing patterns of V{beta} family usage were confirmed by PCR amplification with primers that encompass all of the identified V{beta} families and known clonotypic sequences (see Materials and Methods; data not shown). Moreover, variability in the patterns of dominance of selected V{beta} families in different monkeys also was seen in our previous study of epitope-specific CTL clones (10, 24). This variability also cannot be explained by the existence of multiple subtypes of the Mamu-A*01 allele, where each subtype might select for a different V{beta}+CD8+ T cell subpopulation, because sequencing of the {alpha}2 domain of the Mamu-A*01 allele from >600 animals has demonstrated no polymorphism in that gene in Indian rhesus moneys (data not shown). It is likely that the variation in V{beta} dominance reflects the differences in thymic selection driven by the complexity of MHC haplotypes in outbred species (28). We also cannot exclude the possibility that differences in cytokine profiles among the infected monkeys may contribute to the distinct V{beta} patterns seen in individual animals (29).

The present study provides molecular evidence that some of the dominant V{beta}+ cell subpopulations or clones in the p11C-specific CD8+ T cell population can be stable over time during the course of SIVmac infections. These results are consistent with a recent report describing the persistence of a peptide epitope-specific CTL clone in an HIV-1-infected person (11, 30, 31). The stability of at least a portion of the repertoire of SIVmac p11C-specific CD8+ T cell populations suggests that viral peptide epitope-specific CD8+ T cell clones can continuously proliferate and expand in AIDS virus-infected individuals. Such prolonged expansions of dominant clones may provide an advantage in containing persistent viral replication in infected individuals.

Others of the dominant V{beta}+ cell subpopulations or clones in the p11C-specific CD8+ T cell population appear to vary during the course of SIVmac infections. These changes in the TCR repertoire do not appear to be driven by the emergence of viral mutants, as we were unable to identify a high frequency of mutations in the epitope-coding region of SIVmac gag during the 7-mo follow-up of monkeys 9398 and 9498 (data not shown). Rather, the evolving clonal dominance in the TCR repertoire over time may be driven by host factors, some of which may be consequences of the SIV infection itself. Thus, for example, a burst of viral replication and an associated marked depletion of CD4+ T cells occur during the period of primary SIVmac infection in monkeys. This high viral load and sharp decline in CD4+ T helper cells may affect the proliferation or turn-over of specific CD8+ T lymphocyte clones. These viral and immune changes may, in turn, affect the TCR repertoire of the CD8+ virus-specific CTL. As a result, some clones that are present during primary infection may be replaced by others that emerge during the chronic phase of infection. It is also possible that changes in production of specific cytokines as described above may select for dominant clones in the TCR repertoire during SIV infection of a monkey. Finally, we cannot exclude the possibility that random selection may underlie the changes in clonal dominance in the TCR repertoire of the CD8+ T cell population recognizing the Mamu-A*01/p11C,C-M complex. By whatever mechanism, the results of the present study suggest that some V{beta}+ populations or clones that emerge in the chronically infected monkey can replace previously dominant cell subpopulations in the repertoire of the p11C-specific CD8+ T cell response during SIVmac infections.


    Footnotes
 
1 This work was supported by National Institutes of Health Grants ROI HL64560 (to Z.W.C.) and AI20729 (to N.L.L.). Back

2 Address correspondence and reprint requests to Dr. Zheng W. Chen, 330 Brookline Avenue, RE113, Boston, MA 02215. Back

3 Abbreviations used in this paper: SIVmac, SIV of macaques; CDR3, complementarity-determining region 3. Back

Received for publication November 7, 2000. Accepted for publication January 19, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Show, M. B. A. Oldstone. 1994. Virus specific CD8+ cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103.[Abstract/Free Full Text]
  2. Chen, Z. W., Z. Kou, C. Lekutis, L. Shen, D. Zhou, M. Halloran, J. Li, J. Sodroski, D. Lee-Parritz, N. L. Letvin. 1995. T cell receptor V{beta} repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric of simian-human immunodeficiency virus. J. Exp. Med. 182:21.[Abstract/Free Full Text]
  3. Koup, R. A., J. T. Safrit, Y. Gao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.[Abstract/Free Full Text]
  4. Schmitz, J. E., M. J. Kuroda, S. Santra, V. G. Sasserville, M. A. Simon, M. A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. J. Scallon, et al 1997. Control of viremia in simian immunodefefciency virus infection by CD8+ lymphocytes. Science 283:857.[Abstract/Free Full Text]
  5. Carmichael, A., X. Jin, P. Sissons, L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1(HIV-1)-specific cytotoxic T lymphocyte response at different stages of HIV-1 infection; differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249.[Abstract/Free Full Text]
  6. Klein, M. R., C. A. van Baalen. A. M. Holwerda, S.R. Kerkhof Garde, R. J. Bende, I. P. M. Keet, J. K. M. Eeftinck-Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, F. Miedema. 1995. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.[Abstract/Free Full Text]
  7. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S.L. Rowland-Jones, V. Cerundolo, et al 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103.[Abstract/Free Full Text]
  8. Rinaldo, C., X. L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long term nonprogressors. J. Virol. 69:5838.[Abstract]
  9. Jin, X., D. E. Bauer, S. E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C. E. Irwin, J. T. Safrit, J. Mittler, J. Weinberger, et al 1999. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 15:991.
  10. Chen, Z. W., L. Shen, J. D. Regan, Z. Kou, S. H. Ghim, N. L. Letvin. 1996. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 156:1469.[Abstract]
  11. Kalam, S. A., R. P. Johnson, A. K. Trocha, M.J. Dynan. H. S. Ngo, R.T. D’A quila, J. T. Kurnick, B. D. Walker. 1994. Longitudinal analysis of T cell receptor gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261.[Abstract/Free Full Text]
  12. Pantaleo, G., J. F. Demarest, H. Soudeyns, C. Graziosi, F. Denis, J. W. Adeisberger, P. Borrow, M. S. Saag, G. M. Shaw, R. Sekaly, A. S. Fauci. 1994. Major expansion of CD8+ T cells with a predominant V{beta} usage during the primary immune response to HIV. Nature 370:463.[Medline]
  13. Kolowos, W., M. Schmitt, M. Herrman, E. Harrer, P. Low, J. R. Kalden, T. Harrer. 1999. Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptase-specific CTL clones. J. Immunol. 162:7525.[Abstract/Free Full Text]
  14. Bragado, R., P. Lanzurica, J. Lopez, J. Lopez de Castro. 1990. TCR V gene usage in a human alloreactive response: shared structure feature among HLA-B27 specific T cell clones. J. Exp. Med. 171:1189.[Abstract/Free Full Text]
  15. Aebisher, T. S., Oehen, and H. Hengartner. 1990. Preferential usage of a V{alpha}4 and V{beta}10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells. Eur. J. Immunol. 20:523.
  16. Yanagi, Y., A. Tishon, H. Lewicki, B. Cubitt, M. B. A. Oldstone. 1992. Diversity of T cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. J. Virol. 66:2527.[Abstract/Free Full Text]
  17. Moss, P. A. H., R. J. Moots, W. M. C. Rosenburg, S. J. Rowland-Jones, A. J. McMichael, J. I. Bell. 1991. Extensive conservation of {alpha} and {beta} chains of human T cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA 88:8987.[Abstract/Free Full Text]
  18. Bowness, P., P. A. H. Moss, S. Rowland-Jones, J. I. Bell, A.J. McMichael. 1993. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggest a general pattern for antigen-specific major histocompatibility complex I-restricted response. Eur. J. Immunol.; 23:1417.[Medline]
  19. Lehner, P. J., C. Y. E. Wang, P. A. H. Moss, S. Williams, K. Platt, S. M. Friedman, J. I. Bell, L. K. Borysiewicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V{beta} 17 gene segment. J. Exp. Med.; 181:79.[Abstract/Free Full Text]
  20. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M.G. McHeyzer-Williams, J. I. Bell, A.J. McMichael, M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.[Abstract/Free Full Text]
  21. Kuroda, M. J., J. E. Schmitz, D. H. Barouch, A. Craiu, T. M. Allen, A. Sette, D. I. Watkins, M. A. Forman, N. L. Letvin. 1998. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med.; 187:137.
  22. Chenchik, A. Zhu, Y. Y., Diatchenko, L. Li, R, Hill, J., and Siebert, P. D. 1998. Generation and use of high-quality cDNA from small amounts of total RNA by SMART PCR. In Gene Cloning and Analysis. BioTechniques Books, MA. p. 305.
  23. Ciavatta, V., J. Cairney. 2000. Isolation of full-length cDNA clones using SMART cDNA and a biotin-streptavidin bead system. BioTechniques 29:444.[Medline]
  24. Chen, Z. W., H. Yamamoto, D. I. Watkins, G. Levinson, N. L. Letvin. 1992. A predominant use of a T cell receptor V{beta} gene family in SIV gag-specific cytotoxic T lymphocytes in rhesus monkey. J. Virol. 66:3913.[Abstract/Free Full Text]
  25. Chen, Z. W., Z. Kou, L. Shen, K. A. Reimann, N. L. Letvin. 1993. Conserved T cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 150:2177.
  26. Zhou, D., Y. Shen, L. Chalifoux, M. Halloran, D. Lee-Parritz, M. Simon, P. Sehgal, Z. W. Chen. 1999. Mycobacterium bovis BCG enhances the pathogenicity of simian immunodeficiency virus infection in macaques. J. Immunol. 162:2204.[Abstract/Free Full Text]
  27. Kou, Z., M. Halloran, D. Lee-Perritz, L. Shen, M. Simon, Y. Shen, Z. W. Chen. 1998. In vivo effects of a bacterial superantigen on macaque T cell receptor repertoires. J. Immunol. 160:5170.[Abstract/Free Full Text]
  28. Marrack, P., J. Kappler. 1997. Positive selection of thymocytes bearing {alpha}{beta} T cell receptors. Curr. Opin. Immunol. 9:250.[Medline]
  29. Ku, C. C., M. Murakami, A. Sakamoto, J. Kappler, P. Marrack. 2000. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288:675.[Abstract/Free Full Text]
  30. Wilson, J. D., G. S. Oggs, R. L. Allen, P. J. Goulder, A. Kelleher, A. K. Sewell, C. A. O’Callaghan, S. L. Rowland-Jones, M. F. Callan, A. J. McMichael. 1998. Oligoclonal expansions of CD8+ T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188:785.[Abstract/Free Full Text]
  31. Bieganowska, K., P. Hollsberg, G. J. Buckle, D. G. Lim, T. F. Greten, J. Schneck, J. D. Altman, S. Jacobson, S. L. Ledis, B. Hanchard, J. Chin, O. Morgan, P. A. Roth, D. A. Hafler. 1999. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11–19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J. Immunol. 162:1765.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Wei, D. Huang, X. Lai, M. Chen, W. Zhong, R. Wang, and Z. W. Chen
Definition of APC Presentation of Phosphoantigen (E)-4-Hydroxy-3-methyl-but-2-enyl Pyrophosphate to V{gamma}2V{delta}2 TCR
J. Immunol., October 1, 2008; 181(7): 4798 - 4806.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Venturi, H. Y. Chin, D. A. Price, D. C. Douek, and M. P. Davenport
The Role of Production Frequency in the Sharing of Simian Immunodeficiency Virus-Specific CD8+ TCRs between Macaques
J. Immunol., August 15, 2008; 181(4): 2597 - 2609.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Yang, T. Dong, E. Turnbull, S. Ranasinghe, B. Ondondo, N. Goonetilleke, N. Winstone, K. di Gleria, P. Bowness, C. Conlon, et al.
Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy
J. Immunol., July 1, 2007; 179(1): 597 - 606.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. T. Loffredo, B. J. Burwitz, E. G. Rakasz, S. P. Spencer, J. J. Stephany, J. P. Giraldo Vela, S. R. Martin, J. Reed, S. M. Piaskowski, J. Furlott, et al.
The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape
J. Virol., March 15, 2007; 81(6): 2624 - 2634.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Hasegawa, C. Moriya, H. Liu, W. A. Charini, H. C. Vinet, R. A. Subbramanian, P. Sen, N. L. Letvin, and M. J. Kuroda
Analysis of TCR{alpha}beta Combinations used by Simian Immunodeficiency Virus-Specific CD8+ T Cells in Rhesus Monkeys: Implications for CTL Immunodominance
J. Immunol., March 15, 2007; 178(6): 3409 - 3417.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Chung, W. Lee, J. T. Loffredo, B. Burwitz, T. C. Friedrich, J. P. Giraldo Vela, G. Napoe, E. G. Rakasz, N. A. Wilson, D. B. Allison, et al.
Not All Cytokine-Producing CD8+ T Cells Suppress Simian Immunodeficiency Virus Replication
J. Virol., February 1, 2007; 81(3): 1517 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Messaoudi, J. Warner, M. Fischer, B. Park, B. Hill, J. Mattison, M. A. Lane, G. S. Roth, D. K. Ingram, L. J. Picker, et al.
From the Cover: Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates
PNAS, December 19, 2006; 103(51): 19448 - 19453.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. R. Manuel, W. A. Charini, P. Sen, F. W. Peyerl, M. J. Kuroda, J. E. Schmitz, P. Autissier, D. A. Sheeter, B. E. Torbett, and N. L. Letvin
Contribution of T-Cell Receptor Repertoire Breadth to the Dominance of Epitope-Specific CD8+ T-Lymphocyte Responses
J. Virol., December 15, 2006; 80(24): 12032 - 12040.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Singh and Y. Paterson
Vaccination Strategy Determines the Emergence and Dominance of CD8+ T-Cell Epitopes in a FVB/N Rat HER-2/neu Mouse Model of Breast Cancer.
Cancer Res., August 1, 2006; 66(15): 7748 - 7757.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. L. Turnbull, A. R. Lopes, N. A. Jones, D. Cornforth, P. Newton, D. Aldam, P. Pellegrino, J. Turner, I. Williams, C. M. Wilson, et al.
HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently
J. Immunol., May 15, 2006; 176(10): 6130 - 6146.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Meyer-Olson, K. W. Brady, M. T. Bartman, K. M. O'Sullivan, B. C. Simons, J. A. Conrad, C. B. Duncan, S. Lorey, A. Siddique, R. Draenert, et al.
Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire
Blood, March 15, 2006; 107(6): 2373 - 2383.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Dong, G. Stewart-Jones, N. Chen, P. Easterbrook, X. Xu, L. Papagno, V. Appay, M. Weekes, C. Conlon, C. Spina, et al.
HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor
J. Exp. Med., December 20, 2004; 200(12): 1547 - 1557.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Meyer-Olson, N. H. Shoukry, K. W. Brady, H. Kim, D. P. Olson, K. Hartman, A. K. Shintani, C. M. Walker, and S. A. Kalams
Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape
J. Exp. Med., August 2, 2004; 200(3): 307 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. R. Lopes, A. Jaye, L. Dorrell, S. Sabally, A. Alabi, N. A. Jones, D. R. Flower, A. De Groot, P. Newton, R. M. Lascar, et al.
Greater CD8+ TCR Heterogeneity and Functional Flexibility in HIV-2 Compared to HIV-1 Infection
J. Immunol., July 1, 2003; 171(1): 307 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Boissonnas, O. Bonduelle, A. Antzack, Y.-C. Lone, C. Gache, P. Debre, B. Autran, and B. Combadiere
In Vivo Priming Of HIV-Specific CTLs Determines Selective Cross-Reactive Immune Responses Against Poorly Immunogenic HIV-Natural Variants
J. Immunol., October 1, 2002; 169(7): 3694 - 3699.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Valmori, V. Dutoit, V. Schnuriger, A.-L. Quiquerez, M. J. Pittet, P. Guillaume, V. Rubio-Godoy, P. R. Walker, D. Rimoldi, D. Lienard, et al.
Vaccination with a Melan-A Peptide Selects an Oligoclonal T Cell Population with Increased Functional Avidity and Tumor Reactivity
J. Immunol., April 15, 2002; 168(8): 4231 - 4240.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Douek, M. R. Betts, J. M. Brenchley, B. J. Hill, D. R. Ambrozak, K.-L. Ngai, N. J. Karandikar, J. P. Casazza, and R. A. Koup
A Novel Approach to the Analysis of Specificity, Clonality, and Frequency of HIV-Specific T Cell Responses Reveals a Potential Mechanism for Control of Viral Escape
J. Immunol., March 15, 2002; 168(6): 3099 - 3104.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. F. McKay, J. E. Schmitz, D. H. Barouch, M. J. Kuroda, M. A. Lifton, C. E. Nickerson, D. A. Gorgone, and N. L. Letvin
Vaccine Protection Against Functional CTL Abnormalities in Simian Human Immunodeficiency Virus-Infected Rhesus Monkeys
J. Immunol., January 1, 2002; 168(1): 332 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Bitmansour, S. L. Waldrop, C. J. Pitcher, E. Khatamzas, F. Kern, V. C. Maino, and L. J. Picker
Clonotypic Structure of the Human CD4+ Memory T Cell Response to Cytomegalovirus
J. Immunol., August 1, 2001; 167(3): 1151 - 1163.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Z. W.
Right arrow Articles by Letvin, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Z. W.
Right arrow Articles by Letvin, N. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS